Zhifeng Wei
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
- Berberine and alkaloids research
- Biological Psychiatry top 5%
Papers in
-
- Inflammasome and immune disorders 7
- Immunology 30
- Immune Response and Inflammation 12
- Immune cells in cancer 9
- T-cell and B-cell Immunology 6
- Co-authors
- Yue Dai (71 shared papers)Yufeng Xia (66 shared papers)Qi Lv (12 shared papers)Simiao Qiao (18 shared papers)Yumeng Miao (14 shared papers)Bei Tong (14 shared papers)Yannong Dou (14 shared papers)Mengfan Yue (13 shared papers)
- Journals
- International Immunopharmacology (11 papers)The FASEB Journal (6 papers)British Journal of Pharmacology (4 papers)Acta Pharmacologica Sinica (4 papers)Cell Death and Disease (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Zhifeng Wei
122 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 121
- Pharmacology 483
- Biological Psychiatry 93
- Complementary and alternative medicine 277
- Cancer Research 376
- Immunology 506
Countries citing papers authored by Zhifeng Wei
This map shows the geographic impact of Zhifeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifeng Wei more than expected).
Fields of papers citing papers by Zhifeng Wei
This network shows the impact of papers produced by Zhifeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifeng Wei. The network helps show where Zhifeng Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhifeng Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 151 | |
| 2 | 2016 | 139 | |
| 3 | 2017 | 94 | |
| 4 | 2018 | 89 | |
| 5 | 2018 | 85 | |
| 6 | 2019 | 83 | |
| 7 | 2015 | 72 | |
| 8 | 2018 | 71 | |
| 9 | 2014 | 69 | |
| 10 | 2013 | 68 | |
| 11 | 2013 | 61 | |
| 12 | 2019 | 60 | |
| 13 | 2022 | 58 | |
| 14 | 2020 | 54 | |
| 15 | 2011 | 52 | |
| 16 | 2015 | 46 | |
| 17 | 2013 | 45 | |
| 18 | 2014 | 45 | |
| 19 | 2018 | 44 | |
| 20 | 2012 | 44 |
About Zhifeng Wei
Zhifeng Wei is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Pharmacology, having authored 131 papers that have together received 3.0k indexed citations. Recurring topics across this work include Immune Response and Inflammation (12 papers), Immune cells in cancer (9 papers), NF-κB Signaling Pathways (8 papers), Pharmacological Effects of Natural Compounds (8 papers), Inflammasome and immune disorders (7 papers), Berberine and alkaloids research (7 papers), Cancer-related molecular mechanisms research (7 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Pharmacology (483 citations), Biological Psychiatry (93 citations), Complementary and alternative medicine (277 citations), Cancer Research (376 citations) and Immunology (506 citations). Zhifeng Wei has collaborated with scholars based in China, United States and France. Frequent co-authors include Yue Dai, Yufeng Xia, Qi Lv, Simiao Qiao, Yumeng Miao, Bei Tong, Yannong Dou, Mengfan Yue, Ling Yang and Zhengtao Wang. Their work appears in journals such as International Immunopharmacology, The FASEB Journal, British Journal of Pharmacology, Acta Pharmacologica Sinica and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.